Pharming (PHAR) EBT Margin (2020 - 2026)
Pharming's EBT Margin was 26.53% in Q3 2026, up 13.48 percentage points from 13.05% a year earlier and up 27.58 percentage points from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) EBT Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pharming's EBT Margin was -5.09% through Sep 30, 2026, up 1.36 percentage points year-over-year; for FY2025, it came in at 3.42%, up 8.53 percentage points from FY2024.
- EBT Margin shows a five-year change of -17.37 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was -5.11% in FY2024 (-0.22 pp), -4.90% in FY2023 (-20.99 pp), 16.10% in FY2022 (+4.49 pp) and 11.60% in FY2021 (-9.18 pp).
- The Q3 2026 figure marks the highest quarterly EBT Margin since Q2 2022.
- Compared with a year earlier, EBT Margin has increased for three straight quarters, with an average year-over-year change of +2814445.60 percentage points over the last eight quarters.
- The best year-over-year quarter for EBT Margin over five years was Q2 2025 (a gain of 22515516.84 percentage points); the worst was Q2 2024 (a drop of 22515495.36 percentage points).
- Per Business Quant data, PHAR's EBT Margin in the three quarters before Q3 2026 was -1.05% (Q2 2026), -14.14% (Q1 2026) and 4.51% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 20.41% |
| 10 | Pharming | 898.85 Mn | 429.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 26.53% |
| Jun 30, 2026 | -1.05% |
| Mar 31, 2026 | -6.56% |
| Dec 31, 2025 | 4.51% |
| Sep 30, 2025 | 13.05% |
| Jun 30, 2025 | -2.73% |
| Mar 31, 2025 | -14.90% |
| Dec 31, 2024 | 7.23% |
| Sep 30, 2024 | 2.02% |
| Jun 30, 2024 | -22,515,519.57% |
| Mar 31, 2024 | -29.91% |
| Dec 31, 2023 | -2.46% |
| Sep 30, 2023 | 4.96% |
| Jun 30, 2023 | -24.20% |
| Mar 31, 2023 | -39.20% |
| Dec 31, 2022 | -33.15% |
| Sep 30, 2022 | 17.16% |
| Jun 30, 2022 | 35.53% |
| Mar 31, 2022 | 6.01% |
| Dec 31, 2021 | 8.76% |
API Access
Pharming EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();